PICO Portalanswers from OpenAlex
National Institute of Allergy and Infectious Diseases
FunderResearch funding and supported work
National Institute of Allergy and Infectious Diseases is a funder indexed in PICO Portal from OpenAlex.
What is known about National Institute of Allergy and Infectious Diseases?
PICO Portalrecord summary
US research institute for the treatment and prevention of infectious diseases
How many works does National Institute of Allergy and Infectious Diseases have?
PICO Portalindexed works
National Institute of Allergy and Infectious Diseases has 387,975 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for National Institute of Allergy and Infectious Diseases?
PICO Portalopenalex
The OpenAlex for National Institute of Allergy and Infectious Diseases is on the source record.
What is the ROR of National Institute of Allergy and Infectious Diseases?
PICO Portalror
The ROR for National Institute of Allergy and Infectious Diseases is on the source record.
What are the most-cited papers on National Institute of Allergy and Infectious Diseases?
PICO Portalmost cited works
Stigma, housing and identity after prison
Danya E. Keene, Amy B. Smoyer, Kim M. Blankenship
Familial aggregation of food allergy and sensitization to food allergens: a family‐based study
Hui‐Ju Tsai, Rajesh Kumar, Jacqueline A. Pongracic, X. Liu, R. Story, Yanni Yu, Deanna Caruso, J. Costello, A. Schroeder, Yuqi Fang, Hakan Demirtaş, K.E. Meyer, Maurice R.G. O’Gorman, X. Wang
Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women
Emily S. Barrett, Chongshu Chen, Sally W. Thurston, Line Småstuen Haug, Azemira Sabaredzovic, Frøydis Fjeldheim, Hanne Frydenberg, Susan F. Lipson, Peter T. Ellison, Inger Thune
Prevalence and Severity of Sesame Allergy in the United States
Christopher Warren, Avneet S. Chadha, Scott H. Sicherer, Jialing Jiang, Ruchi S. Gupta
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD
Niels Jongs, Glenn M. Chertow, Tom Greene, John J.V. McMurray, Anna Maria Langkilde, Ricardo Correa‐Rotter, Naoki Kashihara, Peter Rossing, C. David Sjöström, Bergur V. Stefánsson, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink